Literature DB >> 21666116

SPARC regulates collagen interaction with cardiac fibroblast cell surfaces.

Brett S Harris1, Yuhua Zhang, Lauren Card, Lee B Rivera, Rolf A Brekken, Amy D Bradshaw.   

Abstract

Cardiac tissue from mice that do not express secreted protein acidic and rich in cysteine (SPARC) have reduced amounts of insoluble collagen content at baseline and in response to pressure overload hypertrophy compared with wild-type (WT) mice. However, the cellular mechanism by which SPARC affects myocardial collagen is not clearly defined. Although expression of SPARC by cardiac myocytes has been detected in vitro, immunohistochemistry of hearts demonstrated SPARC staining primarily associated with interstitial fibroblastic cells. Primary cardiac fibroblasts isolated from SPARC-null and WT mice were assayed for collagen I synthesis by [(3)H]proline incorporation into procollagen and by immunoblot analysis of procollagen processing. Bacterial collagenase was used to discern intracellular from extracellular forms of collagen I. Increased amounts of collagen I were found associated with SPARC-null versus WT cells, and the proportion of total collagen I detected on SPARC-null fibroblasts without propeptides [collagen-α(1)(I)] was higher than in WT cells. In addition, the amount of total collagen sensitive to collagenase digestion (extracellular) was greater in SPARC-null cells than in WT cells, indicating an increase in cell surface-associated collagen in the absence of SPARC. Furthermore, higher levels of collagen type V, a fibrillar collagen implicated in collagen fibril initiation, were found in SPARC-null fibroblasts. The absence of SPARC did not result in significant differences in proliferation or in decreased production of procollagen I by cardiac fibroblasts. We conclude that SPARC regulates collagen in the heart by modulating procollagen processing and interactions with fibroblast cell surfaces. These results are consistent with decreased levels of interstitial collagen in the hearts of SPARC-null mice being due primarily to inefficient collagen deposition into the extracellular matrix rather than to differences in collagen production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666116      PMCID: PMC3191098          DOI: 10.1152/ajpheart.01247.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

Review 1.  Extracellular matrix remodeling following myocardial injury.

Authors:  Merry L Lindsey; Douglas L Mann; Mark L Entman; Francis G Spinale
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

Review 2.  Collagens: molecular biology, diseases, and potentials for therapy.

Authors:  D J Prockop; K I Kivirikko
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

3.  Expression and purification of recombinant human SPARC produced by baculovirus.

Authors:  A D Bradshaw; J A Bassuk; A Francki; E H Sage
Journal:  Mol Cell Biol Res Commun       Date:  2000-06

4.  Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

Authors:  Amy D Bradshaw; Catalin F Baicu; Tyler J Rentz; An O Van Laer; D Dirk Bonnema; Michael R Zile
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

Review 5.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

6.  Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen.

Authors:  F J Villarreal; W H Dillmann
Journal:  Am J Physiol       Date:  1992-06

7.  Regulation of procollagen metabolism in the pressure-overloaded rat heart.

Authors:  E G Eleftheriades; J B Durand; A G Ferguson; G L Engelmann; S B Jones; A M Samarel
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 8.  Left ventricular diastolic dysfunction and diastolic heart failure.

Authors:  William H Gaasch; Michael R Zile
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

Review 9.  Cardiac interstitium in health and disease: the fibrillar collagen network.

Authors:  K T Weber
Journal:  J Am Coll Cardiol       Date:  1989-06       Impact factor: 24.094

10.  Structural basis of sequence-specific collagen recognition by SPARC.

Authors:  Erhard Hohenester; Takako Sasaki; Camilla Giudici; Richard W Farndale; Hans Peter Bächinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

View more
  32 in total

Review 1.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  MicroRNA-29b-3p Targets SPARC Gene to Protect Cardiocytes against Autophagy and Apoptosis in Hypoxic-Induced H9c2 Cells.

Authors:  Shu Zhou; Dazhou Lei; Faqin Bu; Hongqiang Han; Shucai Zhao; Yan Wang
Journal:  J Cardiovasc Transl Res       Date:  2018-12-17       Impact factor: 4.132

Review 4.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

Review 5.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

6.  Effects of the absence of procollagen C-endopeptidase enhancer-2 on myocardial collagen accumulation in chronic pressure overload.

Authors:  Catalin F Baicu; Yuhua Zhang; An O Van Laer; Ludivine Renaud; Michael R Zile; Amy D Bradshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-18       Impact factor: 4.733

7.  Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis.

Authors:  Lindsay T McDonald; Michael R Zile; Yuhua Zhang; An O Van Laer; Catalin F Baicu; Robert E Stroud; Jeffrey A Jones; Amanda C LaRue; Amy D Bradshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-09       Impact factor: 4.733

8.  Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.

Authors:  Timothy D Bryson; Xiaosong Gu; Remonda M Khalil; Safa Khan; Liping Zhu; Jiang Xu; Edward Peterson; Xiao-Ping Yang; Pamela Harding
Journal:  J Mol Cell Cardiol       Date:  2018-03-06       Impact factor: 5.000

9.  The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

Authors:  Daniel Lavall; Christian Selzer; Pia Schuster; Matthias Lenski; Oliver Adam; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

Review 10.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.